Just Other Articles

Touting “The end of traditional banking,” Washington Mutual took

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

its brand primetime earlier this year with commercial advertising. In addition to providing

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

standard banking and financial services, “WaMu” as it is known, is helping to red

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

fine banking by making “free” accounts, free.

WaMu's goal is to deliver products

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

and services that “offer great value and friendly service.” Their core values in

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

clude being fair, caring, human, dynamic, and driven. Change Sciences partner, Steve Ellis af

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

irms the Banks’ success: "Most people see banking as drudgery. The best banks are

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

working hard to create a kinder, friendlier experience online -- and Washington Mutual has p

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ulled ahead of the others in doing this."

Even though it has just over 2,600 branches,

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

aMu is experienced. The bank has been around since 1889. Within the past year, WaMu began sat

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

urating the market with strategically located retail outlets. From Frankfort, Illinois to Bro

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

nx, New York, WaMu’s brand has become as visible as mainstay banks for each region. In

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

he Atlanta market for example, WaMu retail outlets now stand in tandem with competitors Wacho

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

via, Bank of America, and SunTrust who have dominated the local market for m

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ore than ten years.

Like online bank, ING Direct, WaMu appeals to the price

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

conscious consumer who has not yet developed brand loyalty. Now more likely to read fine prin

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

t, consumers readily compare service options to determine what is really “free.”

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

News for top tier banks, WaMu and banks with similar business models make sense for next gene

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ation bankers who want more than a lifelong money vacuum. If premier banks do not mind their

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

Ps and Qs, they will soon be chanting, “Wash who?” while consumers echo back WaMu

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/89878/justotherarticles-Wash-Who.html">Wash Who?</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/89878/justotherarticles-Wash-Who.html]Wash Who?[/url]

Is basic mortgage loan processor training enough training or not? This is just a start in the financial world. Most mortgage processors have a degree in finance or business. There is an alternative that you can use that will make you more money and will work even better than college training.

The concept of coupons first came into national use in 1902, when American merchants and manufacturers wanted to encourage consumers to buy their products. Breakfast cereals were among some of the first products to utilize the concept of coupons as a consumer incentive.

Tags

Links

Just Other Articles - Wash Who?

Related Articles: